Study to Assess Length of Remission With Intensive Chemotherapy in Rapidly Responding AML Patients.
NCT03902769
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
160
Enrollment
OTHER
Sponsor class
Conditions
Acute Myeloid Leukemia
Interventions
PROCEDURE:
Prescribing conventional chemotherapy while with holding allo-SCT
Sponsor
Rambam Health Care Campus